著者
金沢 勉 岩崎 友也 高橋 麻由 柿沼 健一 江塚 勇 山田 治行
出版者
公益社団法人 日本放射線技術学会
雑誌
日本放射線技術学会雑誌 (ISSN:03694305)
巻号頁・発行日
vol.59, no.8, pp.958-964, 2003-08-20 (Released:2017-06-30)
参考文献数
9
被引用文献数
2 3

Although abducens nerve palsy is a relatively common disease, the abducens nerve has been almost impossible to identify, because it is one of the finest cranial nerves and runs three-dimensionally in the prepontine cistern. Three-dimensional constructive interference in steady state (3D-CISS) is helpful in visualizing fine structural elements in the central nervous system because of its higher spatial resolution and fewer artifacts from cerebrospinal fluid. In this study, we successfully visualized the abducens nerve using 3D-CISS. The procedures were as follows : first, Dorello's canal and the ponto-medullary sulcus were identified as visible, landmarks, and then the abducens nerve was followed to the root exit zone ; second, the gray scale of the original image was inverted to clearly visualize the cisternal course of the nerve and the neighboring small vessels ; and, finally, the entire cisternal course of the nerve was visualized in the same images in both oblique axial and oblique sagittal planes by a multi-planar reconstruction method. This reliable technique can be performed for the diagnosis of abducens nerve palsy.
著者
五十嵐 八枝子 五十嵐 恒夫 大丸 裕武 山田 治 宮城 豊彦 松下 勝秀 平松 和彦
出版者
Japan Association for Quaternary Research
雑誌
第四紀研究 (ISSN:04182642)
巻号頁・発行日
vol.32, no.2, pp.89-105, 1993-05-31 (Released:2009-08-21)
参考文献数
38
被引用文献数
31 37

北海道北部の剣淵盆地と中央部富良野盆地で14C年代の測定と花粉分析により約32,000年間の植生変遷史を復元した. 25,000~32,000yrs BPはエゾマツ/アカエゾマツを主とし, グイマツを混じえたタイガ, 16,000~25,000yrs BP (極相期) は現在のサハリン北部に見られるステップとグイマツ, ハイマツを主とする疎林 (北部) およびグイマツ, ハイマツを主とするタイガ (中央部)が発達した. 12,000~16,000yrs BPは北部でグイマツが衰え, エゾマツ/アカエゾマツとカバノキを主とする森林が発達した. 10,000~12,000yrs BPに著しい寒さの戻り (剣淵亜氷期) があり, グイマツは極相期の規模に回復した. 8,000~10,000yrs BPにグイマツは絶滅し, 8,000yrs BPにコナラ属が急増して現在の森林が形成された.
著者
辻岡 貴之 和田 秀穂 矢田 健一郎 末盛 晋一郎 山田 治 杉原 尚 定平 吉都
出版者
一般社団法人 日本内科学会
雑誌
日本内科学会雑誌 (ISSN:00215384)
巻号頁・発行日
vol.91, no.6, pp.1873-1875, 2002-06-10 (Released:2008-06-12)
参考文献数
8

精巣原発悪性リンパ腫(Primary testicular lymphoma:以下PTL)はstage Iでも精巣摘出術と化学療法のみでは対側精巣と中枢神経系に再発しやすい予後不良の疾患である.今回,我々は初回治療として対側精巣照射及び髄注療法を加えたにもかかわらず, 6年後に中枢神経系に再発した症例を経験したので報告した.
著者
山田治夫著
出版者
養賢堂
巻号頁・発行日
1969
著者
中島 輝一 真野 泰成 大内 かおり 佐藤 大輔 岩田 杏子 樋口 安耶 江原 邦明 加藤 芳徳 廣澤 伊織 田島 正教 土屋 文人 山田 治美 小瀧 一 旭 満里子
出版者
一般社団法人日本医療薬学会
雑誌
医療薬学 (ISSN:1346342X)
巻号頁・発行日
vol.38, no.9, pp.599-608, 2012-09-10 (Released:2013-09-12)
参考文献数
9
被引用文献数
4 17

We established a pharmaceutical outpatient clinic at the International University of Health and Welfare Mita Hospital. In the clinic, pharmacists provide mainly pharmaceutical care for cancer outpatients based on prescriptions from a doctor, and then feed back the contents of medication counseling and information about patients to doctors.In this study, we evaluated the role of the pharmaceutical outpatient clinic. From April to July 2011, we investigated retrospectively the contents of feedback from pharmacists to doctors. The contents consisted of three types of information such as medication counseling, history of side effects and allergy, and uneasiness from patients. Most of this information was on side effects. Approximately 42% of uneasiness from patients was about the side effects of chemotherapy. Furthermore, we conducted a questionnaire survey in 62 cancer outpatients that gave informed consent during the period as mentioned above. The results showed that the degree of understanding of drugs on treatment and prevention of the onset of side effects after consultation was markedly improved compared with those before consulting. Many patients (50/62) felt “uneasiness about treatment" and “some uneasiness" before consultation. However, 88.0% (44/50) of them noted that their “anxiety was eased" after consultation. The degree of reduction in uneasiness in patients with stage Ⅰ and Ⅱ breast cancer was larger than that with stage Ⅲ and Ⅳ. In conclusion, it is suggested that the clinic may play a role which makes it possible to enable cancer outpatients to participate in medical treatment with ease, in addition to enabling support for doctors.